NTRK 융합 유전자 양성 진행성 고형암 시장은 2023-2028년간 9,260만 달러 확대되고, 예측 기간 동안 4.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 이 보고서는 NTRK 융합 유전자 양성 진행성 고형암 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 암 발병률 증가, 암 조기 발견에 대한 관심 증가, 분자진단에 대한 수요 증가로 인해 시장이 주도되고 있습니다.
| 시장 범위 |
| 기준년도 |
2024년 |
| 종료년도 |
2028년 |
| 예측 기간 |
2024-2028년 |
| 성장 모멘텀 |
가속 |
| 2024년 전년 대비 |
4.23% |
| CAGR |
4.5% |
| 증분 금액 |
9,260만 달러 |
이 보고서는 향후 몇 년동안 NTRK 융합 유전자 양성 진행성 고형암 시장의 성장을 가속하는 주요 이유 중 하나로 바이오마커 기반 검사에 대한 높은 수요를 꼽았습니다. 또한, 연구 개발 증가, 기술 발전, 새로운 치료 전략이 시장의 큰 수요를 창출할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 시장 구도
제3장 시장 규모 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2023년)
- 시장 전망(2023-2028년)
제4장 시장 규모 실적
- 세계의 NTRK 융합 유전자 양성 진행성 고형암 시장(2018-2022년)
- 용도별 부문 분석(2018-2022년)
- 지역별 부문 분석(2018-2022년)
- 국가별 부문 분석(2018-2022년)
제5장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제6장 시장 세분화 : 용도별
- 시장 세분화
- 비교 : 용도별
- 임상 : 시장 규모와 예측(2023-2028년)
- 연구 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 용도별
제7장 고객 상황
제8장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측(2023-2028년)
- 유럽 : 시장 규모와 예측(2023-2028년)
- 아시아 : 시장 규모와 예측(2023-2028년)
- 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
- 미국 : 시장 규모와 예측(2023-2028년)
- 영국 : 시장 규모와 예측(2023-2028년)
- 중국 : 시장 규모와 예측(2023-2028년)
- 독일 : 시장 규모와 예측(2023-2028년)
- 일본 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 지역 상황별
제9장 성장 촉진요인, 과제, 기회 및 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회 및 성장 억제요인
제10장 경쟁 구도
제11장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Bayer AG
- Empire Genomics Inc.
- F. Hoffmann La Roche Ltd.
- LGC Clinical Diagnostics Inc.
- NeoGenomics Laboratories Inc.
- OncoDNA SA
제12장 부록
LSH
NTRK Fusion Gene Positive Advanced Solid Tumor Market 2024-2028
The NTRK fusion gene positive advanced solid tumor market is forecasted to grow by USD 92.6 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the NTRK fusion gene positive advanced solid tumor market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of cancer, increasing focus on the early detection of cancer, and growing demand for molecular diagnostics.
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 4.23% |
| CAGR | 4.5% |
| Incremental Value | $92.6 mn |
Technavio's NTRK fusion gene positive advanced solid tumor market is segmented as below:
By Application
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the high demand for biomarker-based tests as one of the prime reasons driving the NTRK fusion gene positive advanced solid tumor market growth during the next few years. Also, increase in research and development and advances in technology and emerging treatment strategies will lead to sizable demand in the market.
The report on the NTRK fusion gene positive advanced solid tumor market covers the following areas:
- NTRK fusion gene positive advanced solid tumor market sizing
- NTRK fusion gene positive advanced solid tumor market forecast
- NTRK fusion gene positive advanced solid tumor market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading NTRK fusion gene positive advanced solid tumor market vendors that include Bayer AG, Empire Genomics Inc., F. Hoffmann La Roche Ltd., LGC Clinical Diagnostics Inc., NeoGenomics Laboratories Inc., and OncoDNA. Also, the NTRK fusion gene positive advanced solid tumor market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global NTRK Fusion Gene Positive Advanced Solid Tumor Market 2018 - 2022
- Historic Market Size - Data Table on Global NTRK Fusion Gene Positive Advanced Solid Tumor Market 2018 - 2022 ($ million)
- 4.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ million)
- 4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
- 6.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
- 6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 6.3 Clinical - Market size and forecast 2023-2028
- Chart on Clinical - Market size and forecast 2023-2028 ($ million)
- Data Table on Clinical - Market size and forecast 2023-2028 ($ million)
- Chart on Clinical - Year-over-year growth 2023-2028 (%)
- Data Table on Clinical - Year-over-year growth 2023-2028 (%)
- 6.4 Research - Market size and forecast 2023-2028
- Chart on Research - Market size and forecast 2023-2028 ($ million)
- Data Table on Research - Market size and forecast 2023-2028 ($ million)
- Chart on Research - Year-over-year growth 2023-2028 (%)
- Data Table on Research - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
7 Customer Landscape
- 7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
- 8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 8.8 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 8.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 8.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 8.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
- 9.1 Market drivers
- 9.2 Market challenges
- 9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 9.4 Market opportunities/restraints
10 Competitive Landscape
- 10.1 Overview
- 10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 10.3 Landscape disruption
- Overview on factors of disruption
- 10.4 Industry risks
- Impact of key risks on business
11 Competitive Analysis
- 11.1 Companies profiled
- 11.2 Market positioning of companies
- Matrix on companies position and classification
- 11.3 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- 11.4 Empire Genomics Inc.
- Empire Genomics Inc. - Overview
- Empire Genomics Inc. - Product / Service
- Empire Genomics Inc. - Key offerings
- 11.5 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 11.6 LGC Clinical Diagnostics Inc.
- LGC Clinical Diagnostics Inc. - Overview
- LGC Clinical Diagnostics Inc. - Product / Service
- LGC Clinical Diagnostics Inc. - Key offerings
- 11.7 NeoGenomics Laboratories Inc.
- NeoGenomics Laboratories Inc. - Overview
- NeoGenomics Laboratories Inc. - Business segments
- NeoGenomics Laboratories Inc. - Key news
- NeoGenomics Laboratories Inc. - Key offerings
- NeoGenomics Laboratories Inc. - Segment focus
- 11.8 OncoDNA SA
- OncoDNA SA - Overview
- OncoDNA SA - Product / Service
- OncoDNA SA - Key offerings
12 Appendix
- 12.1 Scope of the report
- 12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 12.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 12.4 Research methodology
- 12.5 Data procurement
- 12.6 Data validation
- 12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 12.8 Data synthesis
- 12.9 360 degree market analysis
- 360 degree market analysis
- 12.10 List of abbreviations
